Filing Details
- Accession Number:
- 0001209191-21-044606
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-01 19:45:43
- Reporting Period:
- 2021-06-29
- Accepted Time:
- 2021-07-01 19:45:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1783032 | Elevation Oncology Inc. | ELEV | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1765710 | Qiming U.s. Healthcare Fund Ii, L.p. | 11100 Ne 8Th St Suite 200 Bellevue WA 98004 | No | No | Yes | No | |
| 1868862 | Qiming U.s. Healthcare Gp Ii, Llc | 11100 Ne 8Th St Suite 200 Bellevue WA 98004 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-29 | 1,656,577 | $0.00 | 1,656,577 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-06-29 | 401,065 | $0.00 | 2,057,642 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-06-29 | 312,500 | $16.00 | 2,370,142 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2021-06-29 | 7,000,000 | $0.00 | 1,656,577 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2021-06-29 | 1,694,730 | $0.00 | 401,065 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date.
- The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming.
Billionaire Hedge Funds
